Growth hormone (GH) angiogenic effect clinical trial on patients with lower limb critical ischemia. GHAS Study Ensayo clínico sobre el efecto angiogénico de la Hormona de Crecimiento (GH) en pacientes con isquemia crítica de las extremidades inferiores. Estudio GHAS

Trial Profile

Growth hormone (GH) angiogenic effect clinical trial on patients with lower limb critical ischemia. GHAS Study Ensayo clínico sobre el efecto angiogénico de la Hormona de Crecimiento (GH) en pacientes con isquemia crítica de las extremidades inferiores. Estudio GHAS

Recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Oct 2015

At a glance

  • Drugs Somatropin (Primary)
  • Indications Peripheral ischaemia
  • Focus Therapeutic Use
  • Acronyms GHAS
  • Most Recent Events

    • 14 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top